Pfizer-BioNTech is moving into the next stages of development for a version of its COVID-19 antiviral pill that will be safe for children younger than 12 years of age.
Pfizer-BioNTech’s Antiviral Pill For Treating COVID In Kids Has Entered New Trial Phase
by | Mar 10, 2022 | Uncategorized | 0 comments
Recent Comments